ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
A study of the correlation between cognitive function and thyroid hormones in patients with Parkinson's disease.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThe aim of the present study was investigating the relationship between thyroid hormone levels and cognitive function in Parkinson's disease (PD).
methods431 PD patients were continuously enrolled from The First Affiliated Hospital of Kunming Medical University between January 2019 and December 2024. This study classified PD patients into PDNC and PDMCI groups based on the PDMCI diagnostic criteria defined by MDS. Clinical information including age, gender, length of illness, BMI, education, and levodopa equivalent daily dose (LEDD), and the presence of underlying diseases such as hypertension and diabetes mellitus were collected from all subjects, and all subjects completed the assessment of UPDRS-III score, H-Y staging, MMSE, MoCA (Beijing version), HAMA, and HAMD scale and underwent the evaluation of thyroid hormone serum T3, T4, FT3, FT4, TSH, TG, TMab, and aTG levels. The differences in general clinical data and thyroid hormone levels between the two groups were compared, and the correlation between thyroid hormone levels and each clinical data and different cognitive domains was analyzed.
resultsPatients in the PDMCI group were older, had a higher proportion of females, had a longer disease duration but fewer years of education, and had higher UPDRS-III, H-Y staging, HAMA, HAMD scores, and LEDDs and lower TSH (all p < 0.05) than those in the PDNC group, but there were no statistically significant differences in comorbidities or thyroid-related markers. In PD patients, FT3 levels were negatively correlated with age, HAMA score, HAMD score, and H-Y staging; FT3 levels were positively correlated with the total MoCA score (p < 0.05) and attention (r = 0.165, p = 0.001), and this association remained independent and significant after multivariate adjustment and multiple-testing correction. The dose-response relationship between TSH levels and cognitive scores shows a clear inverted U-shape.
conclusionThis study suggests that thyroid hormone dysregulation may be associated with cognitive function in Parkinson's disease patients, though this relationship requires further investigation to confirm. This highlights the need for future research to evaluate whether therapeutic modulation of thyroid function could influence cognitive outcomes during the progression of Parkinson's disease.
Indexed as
Identifiers
42443601What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.